3Patrono C,Roth GJ. Aspirin in ischemic cerebrovascular disease: how strong is the case for a different dosing regimen? Stroke,1996,27: 756-760.
4Roehm E. Low-dose aspirin inhibits arachidonic acid-precipitated platelet aggregation but not collagen-precipitated platelet aggregation. Am J Cardiol,1995,76:637-638.
5Wu KK. Platelet activation mechanisms and markers in arterial thrombosis. J Intern Med, 1996,239:17-34.
6Mueller MR,Salat A,Stangl P, et al. Variable platelet response to low-dose ASA and the risk of limb deterioration in patients submitted to peripheral arterial angioplasty. Thromb Haemost,1997,78:1003-1007.
7Helgason CM,Bolin KM,Hoff JA,et al.Development of aspirin resistance in persons with previous ischemic stroke . Stroke,1994,25:2331-2336.
2BEN-DOR I,KLEIMAN NS,LEV E.Assessment,mechanisms,and clinical implication of variability in platelet response to aspirin and clopidogrel therapy[J].Am J Cardiol,2009,104(2):227-233.
3STEINHUBL SR,TALLEY JD,BRADEN GA,et al.Point-ofcare measured platelet inhibition correlates with a reduced risk of an adverse cardiac event after pereutancous coronary intervention:results of the GOLD(AU-Assessing Ultegra)multicenter study[J].Circulation,2001,103(21):2572-2578.
4FOX KA,MEHTA SR,PETERS R,et al.Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome:the clopidogrel in unstable angina to prevent recurrent ischemic events(CURE)trial[J].Circulation,2004,110(10):1202-1208.
